Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868308 · ClinicalTrials.gov registry record
Screening To Obviate Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 589
- Enrollment target
NCT01868308: Completed study, sponsored by University of Pennsylvania.
NCT01868308 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 589 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01868308 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 589 participants
- Enrollment target
Study Summary
Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervicovaginal biomarkers associated with cervical remodeling in a prospective cohort of symptomatic women with a singleton pregnancy at high risk for preterm birth in an effort to better risk stratify this cohort.
Primary Outcome
The primary outcome is preterm birth defined as delivery before 37 weeks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-06 |
What the finished NCT01868308 record still lists
NCT01868308 is an observational study that tracks outcomes without assigning an intervention. The registered 589 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01868308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01868308 about?
NCT01868308 is a clinical study titled "Screening To Obviate Preterm Birth". Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervic...
What is the current status of trial NCT01868308?
This trial is currently completed. The enrollment target is 589 participants. The study started on 2013-01. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01868308?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
- NCT04747626 · 590 participants · NA
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
- NCT05722938 · 590 participants · Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia